EUROPEAN MEDICAL SOLUTIONS
European Medical Solutions engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium and internationally. It offers R/F solutions, including PLATINUM NEO, a solution that revolutionizes the R/F workflow through an interface and AI-powered image processing; OPTIMA, a performance remote-controlled table designed to provid… Read more
EUROPEAN MEDICAL SOLUTIONS (ALEMS) - Net Assets
Latest net assets as of June 2025: €11.19 Million EUR
Based on the latest financial reports, EUROPEAN MEDICAL SOLUTIONS (ALEMS) has net assets worth €11.19 Million EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€52.28 Million) and total liabilities (€41.09 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €11.19 Million |
| % of Total Assets | 21.4% |
| Annual Growth Rate | 64.96% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 5872.77 |
EUROPEAN MEDICAL SOLUTIONS - Net Assets Trend (2013–2024)
This chart illustrates how EUROPEAN MEDICAL SOLUTIONS's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for EUROPEAN MEDICAL SOLUTIONS (2013–2024)
The table below shows the annual net assets of EUROPEAN MEDICAL SOLUTIONS from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €10.34 Million | +4.52% |
| 2023-12-31 | €9.89 Million | -7.03% |
| 2022-12-31 | €10.64 Million | -2.30% |
| 2021-12-31 | €10.89 Million | +293.26% |
| 2020-12-31 | €-5.63 Million | -34.94% |
| 2019-12-31 | €-4.18 Million | -164.56% |
| 2018-12-31 | €6.47 Million | +439.45% |
| 2017-12-31 | €1.20 Million | -90.87% |
| 2016-12-31 | €13.13 Million | +1630.54% |
| 2015-12-31 | €-858.00K | -111.44% |
| 2014-12-31 | €7.50 Million | +17759.52% |
| 2013-12-31 | €42.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to EUROPEAN MEDICAL SOLUTIONS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2058500000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €547.00K | 5.29% |
| Common Stock | €66.07 Million | 639.06% |
| Total Equity | €10.34 Million | 100.00% |
EUROPEAN MEDICAL SOLUTIONS Competitors by Market Cap
The table below lists competitors of EUROPEAN MEDICAL SOLUTIONS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
House of Jane Inc
PINK:HOJI
|
$49.47K |
|
LadRx Corporation
OTCQB:LADX
|
$49.51K |
|
Daios Plastics S.A.
AT:DAIOS
|
$49.51K |
|
Tatton Asset Management plc
LSE:TAM
|
$49.53K |
|
DENNY'S
BE:DE8
|
$49.41K |
|
WEWORK INDIA MANAGEMENT L
NSE:WEWORK
|
$49.40K |
|
CEBR6F
SA:CEBR6F
|
$49.31K |
|
Stcube
KO:052020
|
$49.27K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in EUROPEAN MEDICAL SOLUTIONS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 9,892,000 to 10,339,000, a change of 447,000 (4.5%).
- Net income of 546,000 contributed positively to equity growth.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €546.00K | +5.28% |
| Other Changes | €-99.00K | -0.96% |
| Total Change | €- | 4.52% |
Book Value vs Market Value Analysis
This analysis compares EUROPEAN MEDICAL SOLUTIONS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.01x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | €2.53 | €4.90 | x |
| 2014-12-31 | €447.33 | €4.90 | x |
| 2015-12-31 | €-35.51 | €4.90 | x |
| 2016-12-31 | €412.01 | €4.90 | x |
| 2017-12-31 | €32.96 | €4.90 | x |
| 2018-12-31 | €136.19 | €4.90 | x |
| 2019-12-31 | €-72.23 | €4.90 | x |
| 2020-12-31 | €-90.60 | €4.90 | x |
| 2021-12-31 | €157.82 | €4.90 | x |
| 2022-12-31 | €2.51 | €4.90 | x |
| 2023-12-31 | €2.34 | €4.90 | x |
| 2024-12-31 | €2.44 | €4.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently EUROPEAN MEDICAL SOLUTIONS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.28%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.21%
- • Asset Turnover: 0.93x
- • Equity Multiplier: 4.69x
- Recent ROE (5.28%) is above the historical average (-579.38%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -5521.43% | -33128.57% | 0.01x | 32.60x | €-2.32 Million |
| 2014 | -59.59% | -88580.00% | 0.00x | 1.18x | €-5.17 Million |
| 2015 | 0.00% | -192875.00% | 0.00x | 0.00x | €-7.63 Million |
| 2016 | -93.96% | -733.09% | 0.11x | 1.18x | €-13.65 Million |
| 2017 | -999.67% | -1984.44% | 0.14x | 3.57x | €-12.11 Million |
| 2018 | -221.41% | -2509.15% | 0.05x | 1.79x | €-14.97 Million |
| 2019 | 0.00% | -1470.27% | 0.16x | 0.00x | €-15.24 Million |
| 2020 | 0.00% | -379.45% | 0.07x | 0.00x | €-798.50K |
| 2021 | -2.23% | -0.63% | 1.05x | 3.36x | €-1.32 Million |
| 2022 | -52.42% | -15.05% | 0.93x | 3.75x | €-6.64 Million |
| 2023 | -7.17% | -1.75% | 0.93x | 4.42x | €-1.70 Million |
| 2024 | 5.28% | 1.21% | 0.93x | 4.69x | €-487.90K |
Industry Comparison
This section compares EUROPEAN MEDICAL SOLUTIONS's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $114,267,667
- Average return on equity (ROE) among peers: -111.90%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| EUROPEAN MEDICAL SOLUTIONS (ALEMS) | €11.19 Million | -5521.43% | 3.67x | $49.45K |
| BioSenic S.A. (BIOS) | $2.38 Million | -535.12% | 9.56x | $1.37 Million |
| Celyad SA (CYAD) | $26.68 Million | -61.66% | 0.65x | $5.17 Million |
| Hyloris Developmentsen Sa (HYL) | $32.14 Million | -19.73% | 0.29x | $68.51 Million |
| Onward Medical N.V. (ONWD) | $-3.89 Million | 0.00% | 0.00x | $110.15 Million |
| Oxurion NV (OXUR) | $109.86 Million | -54.90% | 0.11x | $26.78K |
| Tubize-Fin (TUB) | $518.43 Million | 0.00% | 0.25x | $4.28 Billion |